Avalo Therapeutics AVTX
NASDAQ AVTX
$12.26 -0.10 (-0.81%)
At close: Oct 21, 2026 · 4:00 PM EDT

Avalo Therapeutics (AVTX) Raw Materials (2018)

Updated

Avalo Therapeutics (AVTX) posted Raw Materials of $11,392 for Q4 2018.

Analysis

Avalo Therapeutics (AVTX) Raw Materials (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Avalo Therapeutics 533.82 Mn -158.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 11,392.00
API Access

Avalo Therapeutics Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=AVTX&period=max&api_key=YOUR_API_KEY